TG101348 (SAR302503)

inquiry

Cat No.

CEI-0192

Description

TG-101348 (SAR302503) can selectively inhibit JAK2 with IC50 of 3 nM.

CAS_No

936091-26-8

Molecular Weight

524.68

Purity

>99%

Storage

2 years at -20 centigrade

Targets

JAK2

Molecular Formula

C27H36N6O3S

Chemical Name

N-tert-butyl-3-(5-methyl-2-(4-(2-(pyrrolidin-1-yl)ethoxy)phenylamino)pyrimidin-4-ylamino)benzenesulfonamide

Solubility

DSMO 105 mg/mL Water

In vitro

TG-101348 also significantly inhibits JAK2 V617F, Flt3, and Ret with IC50 of 3 nM, 15 nM, and 48 nM, respectively. TG-101348 also inhibits proliferation of parental Ba/F3 cells to a comparable level, with IC50 of ~420 nM. TG101348 treatment decreases GATA-1 expression, which is associated with erythroid-skewing of JAK2V617F+ progenitor differentiation, and inhibits STAT5 as well as GATA S310 phosphorylation.

In vivo

Oral administration of TG101348 (120 mg/kg) significantly inhibits PV progenitor erythroid differentiation in vivo.

Name:

Email *

Phone:*

Company/Institution:

Country or Region:

Quantity:

Services & Products Interested *

Project Description:

Our Products Cannot Be Used As Medicines Directly For Personal Use.

Products

Online Inquiry